1. Plasma claudin-3 is associated with tumor necrosis factor-alpha-induced intestinal endotoxemia in liver disease
- Author
-
Ivano Biviano, Hui Liu, Zhaohan Wang, Aiyao Wang, Jianfang Hu, and Zhibin Gong
- Subjects
Adult ,Liver Cirrhosis ,Male ,medicine.medical_specialty ,Carcinoma, Hepatocellular ,Cirrhosis ,Peritonitis ,Gastroenterology ,Permeability ,Interferon-gamma ,03 medical and health sciences ,Liver disease ,Hepatitis B, Chronic ,0302 clinical medicine ,Spontaneous bacterial peritonitis ,Interferon ,Internal medicine ,medicine ,Claudin-3 ,Humans ,Interferon gamma ,Lactic Acid ,Intestinal Mucosa ,Aged ,Probability ,Analysis of Variance ,Intestinal permeability ,Hepatology ,Tumor Necrosis Factor-alpha ,business.industry ,Liver Neoplasms ,Acute-On-Chronic Liver Failure ,Middle Aged ,medicine.disease ,Endotoxemia ,Endotoxins ,Intestinal Diseases ,Case-Control Studies ,030220 oncology & carcinogenesis ,Hepatocellular carcinoma ,Female ,030211 gastroenterology & hepatology ,Tumor necrosis factor alpha ,business ,Biomarkers ,medicine.drug - Abstract
To investigate intestinal endotoxemia (IETM), intestinal permeability (IP) and cytokine activity in patients with liver cirrhosis (LC).Twenty-nine patients with chronic hepatitis B (CHB), 28 with compensated LC, 33 with decompensated LC, 24 with spontaneous bacterial peritonitis (SBP), 26 with acute-on-chronic liver failure (ACLF), and 24 with decompensated LC complicated by hepatocellular carcinoma (HCC) were recruited. Thirty-one healthy people were included as a control group. Plasma tumor necrosis factor (TNF)-α, interferon (IFN)-γ, D-lactate, endotoxin, and claudin-3 levels were assayed. Data were compared using Pearson correlation testing and analysis of variance, with P 0.05 considered significant.TNF-α, claudin-3, and endotoxin levels were significantly increased (P 0.05) in the plasma of all patients with liver disease compared with that of controls, particularly in patients with decompensated LC, SBP, ACLF, or HCC (P 0.01). IFN-γ was significantly higher in HCC than in other liver diseases (P 0.01). Plasma D-lactate was significantly decreased in all liver diseases, except SBP (P 0.01). TNF-α, endotoxin, and claudin-3 levels were positively correlated (P 0.01), but correlations of IFN-γ with endotoxin or claudin-3 were not significant. The plasma D-lactate level did not significantly correlate with either TNF-α, endotoxin, or claudin-3 levels.Plasma claudin-3, but not D-lactate, was found to be a marker of IP in patients with liver diseases. Elevated plasma TNF-α in such patients was likely to have injured the intestinal barrier, leading to IETM, especially in end-stage LC.
- Published
- 2019